|
TRIM62 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.545900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.258200E-02 |
| Normal-vs-Stage2 |
4.033200E-01 |
| Normal-vs-Stage3 |
1.981770E-03 |
| Normal-vs-Stage4 |
1.437640E-01 |
| Stage1-vs-Stage2 |
3.932600E-01 |
| Stage1-vs-Stage3 |
5.169800E-02 |
| Stage1-vs-Stage4 |
9.138600E-01 |
| Stage2-vs-Stage3 |
4.234300E-02 |
| Stage2-vs-Stage4 |
5.607200E-01 |
| Stage3-vs-Stage4 |
1.652230E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.328310E-02 |
| Normal-vs-AfricanAmerican |
2.375600E-01 |
| Normal-vs-Asian |
3.284400E-01 |
| Caucasian-vs-AfricanAmerican |
5.809600E-01 |
| Caucasian-vs-Asian |
2.605000E-01 |
| AfricanAmerican-vs-Asian |
7.958000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.618190E-01 |
| Normal-vs-Female |
1.352450E-02 |
| Male-vs-Female |
2.142600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.803800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.377100E-03 |
| Normal-vs-Age(61-80Yrs) |
5.659800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.442210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.108800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.144800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.942600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.825800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.049800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.958600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.617550E-03 |
| Classical-VS-Follicular |
6.115400E-01 |
| Classical-VS-Other |
1.268780E-01 |
| Classical-VS-Normal |
1.111650E-01 |
| Tall-VS-Follicular |
2.802500E-02 |
| Tall-VS-Other |
8.466400E-01 |
| Tall-VS-Normal |
2.958300E-04 |
| Follicular-VS-Other |
2.867000E-01 |
| Follicular-VS-Normal |
9.012200E-02 |
| Other-VS-Normal |
2.440100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.822300E-02 |
| Normal-vs-N1 |
2.123900E-02 |
| N0-vs-N1 |
5.808000E-01 |
|
|
